journal article·2021-04Open access

In Vitro Primary‐Indirect Genotoxicity in Bronchial Epithelial Cells Promoted by Industrially Relevant Few‐Layer Graphene

Michael J. Burgum, Martin J. D. Clift, Stephen J. Evans, Nicole Hondow, Mark Miller, Sandra Bustamante Lopez, Adam Williams, Afshin Tarat, Gareth J. Jenkins, Shareen H. Doak

Small· Volume 17· Issue 15

Abstract

Abstract Few‐layer graphene (FLG) has garnered much interest owing to applications in hydrogen storage and reinforced nanocomposites. Consequently, these engineered nanomaterials (ENMs) are in high demand, increasing occupational exposure. This investigation seeks to assess the inhalation hazard of industrially relevant FLG engineered with: (i) no surface functional groups (neutral), (ii) amine, and (iii) carboxyl group functionalization. A monoculture of human lung epithelial (16HBE14o‐) cells is exposed to each material for 24‐h, followed by cytotoxicity and genotoxicity evaluation using relative population doubling (RPD) and the cytokinesis‐blocked micronucleus (CBMN) assay, respectively. Neutral‐FLG induces the greatest (two‐fold) significant increase (p < 0.05) in micronuclei, whereas carboxyl‐FLG does not induce significant (p < 0.05) genotoxicity. These findings correlate to significant (p < 0.05) concentration‐dependent increases in interleukin (IL)‐8, depletion of intracellular glutathione (rGSH) and a depletion in mitochondrial ATP production. Uptake of FLG is evaluated by transmission electron microscopy, whereby FLG particles are observed within membrane‐bound vesicles in the form of large agglomerates (>1 µm diameter). The findings of the present study have demonstrated the capability of neutral‐FLG and amine‐FLG to induce genotoxicity in 16HBE14o‐ cells through primary indirect mechanisms, suggesting a possible role for carboxyl groups in scavenging radicals produced via oxidative stress.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications · Graphene research and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Life Science, Swansea University Medical School Swansea University Singleton Park Swansea Wales SA2 8PP UK

School of Chemical and Process Engineering University of Leeds Leeds LS2 9JT UK

Centre for Cardiovascular Science The University of Edinburgh, Queens Medical Research Institute Edinburgh EH16 4TJ UK

Department of Physics Swansea University Singleton Park Swansea Wales SA2 8PP UK

Perpetuus Carbon Technologies Unit B1, Olympus Court, Millstream Way, Swansea Vale, Llansamlet Swansea SA70AQ UK

Funding

European Social Fund · British Heart Foundation

References (45)

Show source-provided references
1. 10.1016/j.taap.2011.11.01010.1016/j.taap.2011.11.010 ↗
2. European Commission · Off. J. Eur. Union. · 2011 · 275 · 38
3. 10.1186/1743-8977-2-810.1186/1743-8977-2-8 ↗
4. 10.1615/JEnvironPatholToxicolOncol.201802600910.1615/JEnvironPatholToxicolOncol.2018026009 ↗
5. 10.1289/EHP42410.1289/EHP424 ↗
6. 10.1021/acsnano.8b0475810.1021/acsnano.8b04758 ↗
7. 10.1186/s12967-014-0296-910.1186/s12967-014-0296-9 ↗
8. 10.1038/nature0423510.1038/nature04235 ↗
9. 10.1021/nl073187210.1021/nl0731872 ↗
10. 10.1126/science.115799610.1126/science.1157996 ↗
11. 10.1186/s11671-016-1354-410.1186/s11671-016-1354-4 ↗
12. 10.1016/j.ejps.2018.07.00610.1016/j.ejps.2018.07.006 ↗
13. 10.1021/tx200339h10.1021/tx200339h ↗
14. 10.1155/2016/585103510.1155/2016/5851035 ↗
15. 10.1021/nn100717610.1021/nn1007176 ↗
16. 10.1016/j.biomaterials.2011.09.09110.1016/j.biomaterials.2011.09.091 ↗
17. 10.3390/ijms1911356410.3390/ijms19113564 ↗
18. 10.1002/jemt.2269010.1002/jemt.22690 ↗
19. Stewart C. E. · J. Allergy (Cairo) · 2012 · 2012 · 943982
20. 10.1002/em.2201710.1002/em.22017 ↗
21. 10.1006/bbrc.1996.588010.1006/bbrc.1996.5880 ↗
22. 10.1002/em.102310.1002/em.1023 ↗
23. 10.1007/s11051-013-1829-510.1007/s11051-013-1829-5 ↗
24. 10.1021/acsnano.7b0370810.1021/acsnano.7b03708 ↗
25. 10.1016/j.biomaterials.2009.04.00910.1016/j.biomaterials.2009.04.009 ↗
26. 10.1186/1743-8977-10-2710.1186/1743-8977-10-27 ↗
27. 10.1016/j.toxlet.2015.05.02110.1016/j.toxlet.2015.05.021 ↗
28. 10.1038/s41598-018-33414-x10.1038/s41598-018-33414-x ↗
29. 10.1093/carcin/bgm24310.1093/carcin/bgm243 ↗
30. 10.1002/tox.2062110.1002/tox.20621 ↗
31. 10.1186/s12989-019-0291-710.1186/s12989-019-0291-7 ↗
32. 10.1016/j.biomaterials.2013.11.02010.1016/j.biomaterials.2013.11.020 ↗
33. 10.1016/j.addr.2016.08.00910.1016/j.addr.2016.08.009 ↗
34. 10.1002/adma.20120267810.1002/adma.201202678 ↗
35. 10.1080/17435390.2017.133225310.1080/17435390.2017.1332253 ↗
36. Thorley A. J. · Int. J. Chronic Obstruct. Pulmon. Dis. · 2007 · 2 · 409
37. 10.1021/nn204229f10.1021/nn204229f ↗
38. 10.5114/ceji.2016.6589410.5114/ceji.2016.65894 ↗
39. 10.1038/sj.bjp.070590910.1038/sj.bjp.0705909 ↗
40. 10.1289/ehp.080023510.1289/ehp.0800235 ↗
41. 10.1186/s12989-016-0161-510.1186/s12989-016-0161-5 ↗
42. 10.1016/j.biomaterials.2011.09.08710.1016/j.biomaterials.2011.09.087 ↗
43. 10.1111/cei.1266210.1111/cei.12662 ↗
44. 10.1016/j.toxlet.2010.11.01610.1016/j.toxlet.2010.11.016 ↗
45. 10.1038/srep3954810.1038/srep39548 ↗